Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rival permanent heart implants enter human trials

This article was originally published in Clinica

Executive Summary

US company Arrow International last week announced the first clinical implant of its permanent heart replacement device for patients with end-stage heart failure. At the same time, its competitor Abiomed said that it was ready to start human trials of its permanent device, assuming it gets regulatory approval, now that it is producing clinically configured versions of the AbioCor pump.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel